Companies: 10,795·Total market cap: $144.5T
Coloplast A/S

Coloplast A/S

CLPBYOTCHealthcare● Active
$5.94
$-0.02(-0.34%)
Market Cap$13.4B
P/E Ratio—
52W High$10.03
52W Low$5.88
Cash on HandFinancialsRevenue

Coloplast A/S (CLPBY) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CLPBY · cash on hand · updated Sep 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$948.9M▲ +20.4% vs prior year
FY · as of Sep 30, 2025 · Reported in DKK
Cash & Cash Equiv. (CCE)
$948.9M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+20.4%
vs prior fiscal year
Latest Quarter
$1.07B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in DKK

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: September 30, 2025

Net cash vs debt

Cash & ST Investments$948.9MCash on Hand
Total Debt$22.68BTotal Debt
Net Cash / Net Debt−$21.74BNet Debt Position
Cash vs Debt Ratio
Cash 4%Debt 96%

Coloplast A/S carries a net debt position of $21.74B. Total debt ($22.68B) exceeds cash on hand ($948.9M). Coloplast A/S cash vs debt ratio: 4% cash / 96% debt.

Net Cash = Cash & ST Investments − Total Debt$948.9M − $22.68B = −$21.74B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CLPBY annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Sep 30, 2025Latest$948.9M+20.4%
Sep 30, 2024$788.0M-13.5%
Sep 30, 2023$911.0M+43.9%
Sep 30, 2022$633.0M-6.1%
Sep 30, 2021$674.0M+15.2%
CLPBY cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Coloplast A/S
Coloplast A/SYOU
CLPBY
$948.9M7.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Coloplast A/S (CLPBY) cash on hand as of September 30, 2025 is $948.9M, comprising $948.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Coloplast A/S cash and short-term investments on the balance sheet (10-K filing). Also referred to as Coloplast A/S cash reserves or cash position.

Coloplast A/S annual cash on hand history shows increased +20.4% in 2025: increased +20.4% in 2025. Coloplast A/S cash reserves in 2025 reflect the company's capital allocation strategy.

Coloplast A/S carries total debt of $22.68B against cash of $948.9M, resulting in a net debt position of -$21.74B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

CLPBY cash on hand · 5 questions

As of September 30, 2025, Coloplast A/S (CLPBY) has $948,881,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $948,881,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $1.07B. Data sourced from the annual 10-K filing via FMP.

CLPBY cash on handCLPBY cash reservesCLPBY cash 2025how much cash does CLPBY have

▸ Source: FMP /balance-sheet-statement · US GAAP · Coloplast A/S · Coloplast A/S SEC 10-K & 10-Q filings · US GAAP · Last updated: September 30, 2025